Ten years ago the cloning of two interleukin-l molecules (IL-1 alpha a
nd IL-1 beta) resolved the question of whether a single polypeptide co
uld evoke a wide variety of biological effects. During the past decade
, the biology of IL-1 has greatly expanded our understanding of how th
e host responds to external challenges, such as injury and infection,
as well as its role in several diseases. We learned of the remarkable
potency of IL-1 in the femtomolar range and of its ability to induce a
response by triggering only one or two receptors per cell. Unexpected
ly, the IL-1 family of genes, receptors and associated molecules have
been linked to those of Drosophila, nematodes, and microorganisms and
IL-1 signal transduction is similar to that observed after cellular st
ress. The cloning of IL-1 opened other avenues of fundamental biologic
al interest. For example, in addition to the two agonist molecules IL-
1 alpha and IL-1 beta, a third member of the IL-1 gene family is a spe
cific, high affinity receptor antagonist (IL-I receptor antagonist). T
hat this third member of the IL-1 family inhibits the other two is cha
racteristic of the tight control over production and activity exerted
on IL-1. Although IL-1 contributes to the pathogenesis of many disease
s, a small amount appears to be needed to combat infection and initita
te healing processes. This article highlights 10 years of discoveries
on IL-1.-Dinarello, C.A. The interleukin-l family: 10 years of discove
ry.